These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34895644)

  • 1. Microbial technologies for biotherapeutics production: Key tools for advanced biopharmaceutical process development and control.
    Zalai D; Kopp J; Kozma B; Küchler M; Herwig C; Kager J
    Drug Discov Today Technol; 2020 Dec; 38():9-24. PubMed ID: 34895644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Development Strategies for Biopharmaceutical Cell Culture Processes.
    Zalai D; Golabgir A; Wechselberger P; Putics A; Herwig C
    Curr Pharm Biotechnol; 2015; 16(11):983-1001. PubMed ID: 26205158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modeling and process analytical technology for continuous chromatography of biopharmaceutical products.
    Khanal O
    Curr Opin Biotechnol; 2022 Dec; 78():102796. PubMed ID: 36152423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a Digital Bioprocess Replica: Computational Approaches in Biopharmaceutical Development and Manufacturing.
    Smiatek J; Jung A; Bluhmki E
    Trends Biotechnol; 2020 Oct; 38(10):1141-1153. PubMed ID: 32518043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioprocessing in the Digital Age: The Role of Process Models.
    Narayanan H; Luna MF; von Stosch M; Cruz Bournazou MN; Polotti G; Morbidelli M; Butté A; Sokolov M
    Biotechnol J; 2020 Jan; 15(1):e1900172. PubMed ID: 31486583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process Analytical Technologies - Advances in bioprocess integration and future perspectives.
    Gerzon G; Sheng Y; Kirkitadze M
    J Pharm Biomed Anal; 2022 Jan; 207():114379. PubMed ID: 34607168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
    Szkodny AC; Lee KH
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():141-165. PubMed ID: 35300518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology outlook for real-time quality attribute and process parameter monitoring in biopharmaceutical development-A review.
    Wasalathanthri DP; Rehmann MS; Song Y; Gu Y; Mi L; Shao C; Chemmalil L; Lee J; Ghose S; Borys MC; Ding J; Li ZJ
    Biotechnol Bioeng; 2020 Oct; 117(10):3182-3198. PubMed ID: 32946122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced strategies in glycosylation prediction and control during biopharmaceutical development: Avenues toward industry 4.0.
    Puranik A; Saldanha M; Chirmule N; Dandekar P; Jain R
    Biotechnol Prog; 2022 Sep; 38(5):e3283. PubMed ID: 35752935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study.
    Bareither R; Bargh N; Oakeshott R; Watts K; Pollard D
    Biotechnol Bioeng; 2013 Dec; 110(12):3126-38. PubMed ID: 23775295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical review of recent trends, and a future perspective of optical spectroscopy as PAT in biopharmaceutical downstream processing.
    Rolinger L; Rüdt M; Hubbuch J
    Anal Bioanal Chem; 2020 Apr; 412(9):2047-2064. PubMed ID: 32146498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaheuristic approaches in biopharmaceutical process development data analysis.
    Gangadharan N; Turner R; Field R; Oliver SG; Slater N; Dikicioglu D
    Bioprocess Biosyst Eng; 2019 Sep; 42(9):1399-1408. PubMed ID: 31119388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational and systematic protein purification process development: the next generation.
    Nfor BK; Verhaert PD; van der Wielen LA; Hubbuch J; Ottens M
    Trends Biotechnol; 2009 Dec; 27(12):673-9. PubMed ID: 19815300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Plant Productivity in the Post-Genomics Era.
    Thao NP; Tran LS
    Curr Genomics; 2016 Aug; 17(4):295-6. PubMed ID: 27499678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a widespread adoption of metabolic modeling tools in biopharmaceutical industry: a process systems biology engineering perspective.
    Richelle A; David B; Demaegd D; Dewerchin M; Kinet R; Morreale A; Portela R; Zune Q; von Stosch M
    NPJ Syst Biol Appl; 2020 Mar; 6(1):6. PubMed ID: 32170148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biotechnology of animal cells: the road to prediction.
    Carinhas N; Oliveira R; Alves PM; Carrondo MJ; Teixeira AP
    Trends Biotechnol; 2012 Jul; 30(7):377-85. PubMed ID: 22541337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioprocess Economic Modeling: Decision Support Tools for the Development of Stem Cell Therapy Products.
    Salvador WOS; Ribeiro IAB; Nogueira DES; Ferreira FC; Cabral JMS; Rodrigues CAV
    Bioengineering (Basel); 2022 Dec; 9(12):. PubMed ID: 36550997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data integrity within the biopharmaceutical sector in the era of Industry 4.0.
    Alosert H; Savery J; Rheaume J; Cheeks M; Turner R; Spencer C; S Farid S; Goldrick S
    Biotechnol J; 2022 Jun; 17(6):e2100609. PubMed ID: 35318814
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.